Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0O9VW
|
||||
Former ID |
DIB000581
|
||||
Drug Name |
Lanperisone
|
||||
Synonyms |
NK-433
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Nervous and musculoskeletal disorders [ICD10:R25-R29] | Phase 3 | [527704] | ||
Company |
Nippon Kayaku Co Ltd
|
||||
Structure |
Download2D MOL |
||||
Formula |
C15H18F3NO
|
||||
Canonical SMILES |
C(c1ccc(C(=O)[C@@H](CN2CCCC2)C)cc1)(F)(F)F
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Sodium channel protein type 4 subunit alpha | Target Info | Modulator | [527704] | |
Reactome | Interaction between L1 and Ankyrins | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.